Cardio Diagnostics Holdings, Inc.
CDIO
$1.94
-$0.05-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 200.00% | -20.00% | -56.06% | -5.06% | -94.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 200.00% | -20.00% | -56.06% | -5.06% | -94.34% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 200.00% | -20.00% | -56.06% | -5.06% | -94.34% |
| SG&A Expenses | 12.60% | -40.28% | 21.12% | 30.68% | -64.71% |
| Depreciation & Amortization | -87.89% | 230.96% | -- | -- | 845.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.56% | -3.56% | 21.12% | 30.68% | -60.91% |
| Operating Income | -9.46% | 3.51% | -21.48% | -30.89% | 60.78% |
| Income Before Tax | -9.36% | 3.55% | -21.37% | -30.68% | 60.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.36% | 3.55% | -21.37% | -30.68% | 60.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.36% | 3.55% | -21.37% | -30.68% | 60.73% |
| EBIT | -9.46% | 3.51% | -21.48% | -30.89% | 60.78% |
| EBITDA | -12.29% | 4.39% | -22.28% | -32.32% | 63.55% |
| EPS Basic | 35.08% | 30.42% | 43.74% | 43.37% | 83.64% |
| Normalized Basic EPS | 35.09% | 30.43% | 43.74% | 43.37% | 83.64% |
| EPS Diluted | 35.08% | 30.42% | 43.74% | 43.37% | 83.64% |
| Normalized Diluted EPS | 35.09% | 30.43% | 43.74% | 43.37% | 83.64% |
| Average Basic Shares Outstanding | 68.48% | 38.63% | 115.75% | 130.76% | 139.98% |
| Average Diluted Shares Outstanding | 68.48% | 38.63% | 115.75% | 130.76% | 139.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |